New laser resurfacing therapy promising for actinic keratoses

January 11, 2013
New laser resurfacing therapy promising for actinic keratoses
For patients with facial photodamage and actinic keratoses, treatment with a new fractional resurfacing technique that uses a 1927-nm nonablative thulium laser reduces the number of facial actinic keratoses and produces noticeable improvement in overall photodamage, according to a study published in the January issue of the Journal of the American Academy of Dermatology.

(HealthDay)—For patients with facial photodamage and actinic keratoses (AK), treatment with a new fractional resurfacing technique that uses a 1927-nm nonablative thulium laser reduces the number of facial AK and produces noticeable improvement in overall photodamage, according to a study published in the January issue of the Journal of the American Academy of Dermatology.

In an effort to evaluate the efficacy, safety, and tolerability of a fractional resurfacing technique that utilizes a nonablative 1927-nm thulium laser, Elliot T. Weiss, M.D., of the Laser & Skin Surgery Center of New York in New York City, and colleagues conducted a six-month prospective study involving 24 individuals with facial photodamage and AK. Patients received up to four treatments at two- to six-week intervals and were evaluated at one, three, and six months after the final treatment.

The researchers found that, at one month after the final treatment, there was a 91.3 percent reduction in the average number of facial AK from baseline (from 14.4 to 1.22). This effect was sustained at three and six months, with 87.3 and 86.6 percent reductions, respectively, in the absolute number of lesions. At six months, a marked or noticeable improvement in overall photodamage was reported.

"The clinical and histologic findings, as well as the reported patient satisfaction and safety, suggest that the of AK and photodamage with a fractionated 1927-nm nonablative thulium laser is a promising new therapeutic option," the authors write.

Two authors are investigators with Solta Medical, manufacturers of the laser used in the study.

Explore further: Fractional, ablative er:YAG laser akin for skin resurfacing

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Fractional, ablative er:YAG laser akin for skin resurfacing

November 10, 2012
(HealthDay)—Multiple sessions of fractional laser treatment with erbium:yttrium-aluminum-garnet (Er:YAG) for facial resurfacing are comparable to a single ablative Er:YAG laser treatment, according to a small study published ...

Safety, efficacy of at-home laser for periobital wrinkles studied

October 24, 2012
(HealthDay)—A handheld nonablative fractional laser is safe and seems effective for home use for treating periorbital wrinkles, according to a study published in the November issue of the Journal of the American Academy ...

Pulsed dye laser effective on port-wine stains in infants

February 28, 2012
(HealthDay) -- Pulsed dye laser (PDL) treatment at two-, three-, and four-week intervals is effective for infants with facial port-wine stains (PWS), with minimal short-term side effects, according to a study published online ...

Dual mode laser therapy effectively treats acne vulgaris

March 27, 2012
(HealthDay) -- A series of Nd:YAG laser treatments effectively and rapidly reduces both inflammatory and noninflammatory acne vulgaris lesions, according to a study published in the April issue of the Journal of the American ...

Diode laser efficient, safe for tonsillotomy in children

August 7, 2012
(HealthDay) -- A fiber-guided 1,470 nm diode laser system is safe and effective for tonsillotomy in the treatment of obstructive tonsillar hypertrophy in children, according to a study published online July 26 in Lasers in ...

Recommended for you

Co-infection with two common gut pathogens worsens malnutrition in mice

July 27, 2017
Two gut pathogens commonly found in malnourished children combine to worsen malnutrition and impair growth in laboratory mice, according to new research published in PLOS Pathogens.

Finish your antibiotics course? Maybe not, experts say

July 27, 2017
British disease experts on Thursday suggested doing away with the "incorrect" advice to always finish a course of antibiotics, saying the approach was fuelling the spread of drug resistance.

Phase 3 trial confirms superiority of tocilizumab to steroids for giant cell arteritis

July 26, 2017
A phase 3 clinical trial has confirmed that regular treatment with tocilizumab, an inhibitor of interleukin-6, successfully reduced both symptoms of and the need for high-dose steroid treatment for giant cell arteritis, the ...

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Male hepatitis B patients suffer worse liver ailments, regardless of lifestyle

July 25, 2017
Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.